Literature DB >> 24557103

The endocannabinoid anandamide inhibits voltage-gated sodium channels Nav1.2, Nav1.6, Nav1.7, and Nav1.8 in Xenopus oocytes.

Dan Okura1, Takafumi Horishita, Susumu Ueno, Nobuyuki Yanagihara, Yuka Sudo, Yasuhito Uezono, Takeyoshi Sata.   

Abstract

BACKGROUND: Anandamide is an endocannabinoid that regulates multiple physiological functions by pharmacological actions, in a manner similar to marijuana. Recently, much attention has been paid to the analgesic effect of endocannabinoids in terms of identifying new pharmacotherapies for refractory pain management, but the mechanisms of the analgesic effects of anandamide are still obscure. Voltage-gated sodium channels are believed to play important roles in inflammatory and neuropathic pain. We investigated the effects of anandamide on 4 neuronal sodium channel α subunits, Nav1.2, Nav1.6, Nav1.7, and Nav1.8, to explore the mechanisms underlying the antinociceptive effects of anandamide.
METHODS: We studied the effects of anandamide on Nav1.2, Nav1.6, Nav1.7, and Nav1.8 α subunits with β1 subunits by using whole-cell, 2-electrode, voltage-clamp techniques in Xenopus oocytes.
RESULTS: Anandamide inhibited sodium currents of all subunits at a holding potential causing half-maximal current (V1/2) in a concentration-dependent manner. The half-maximal inhibitory concentration values for Nav1.2, Nav1.6, Nav1.7, and Nav1.8 were 17, 12, 27, and 40 μmol/L, respectively, indicating an inhibitory effect on Nav1.6, which showed the highest potency. Anandamide raised the depolarizing shift of the activation curve as well as the hyperpolarizing shift of the inactivation curve in all α subunits, suggesting that sodium current inhibition was due to decreased activation and increased inactivation. Moreover, anandamide showed a use-dependent block in Nav1.2, Nav1.6, and Nav1.7 but not Nav1.8.
CONCLUSION: Anandamide inhibited the function of α subunits in neuronal sodium channels Nav1.2, Nav1.6, Nav1.7, and Nav1.8. These results help clarify the mechanisms of the analgesic effects of anandamide.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24557103     DOI: 10.1213/ANE.0000000000000070

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  7 in total

1.  Peripheral inflammation affects modulation of nociceptive synaptic transmission in the spinal cord induced by N-arachidonoylphosphatidylethanolamine.

Authors:  Vladimir Nerandzic; Petra Mrozkova; Pavel Adamek; Diana Spicarova; Istvan Nagy; Jiri Palecek
Journal:  Br J Pharmacol       Date:  2017-06-11       Impact factor: 8.739

2.  Cannabidiol Mellows Out Resurgent Sodium Current.

Authors:  Christopher H Thompson; Jennifer A Kearney
Journal:  Epilepsy Curr       Date:  2016 Nov-Dec       Impact factor: 7.500

Review 3.  Structure and function of μ-conotoxins, peptide-based sodium channel blockers with analgesic activity.

Authors:  Brad R Green; Grzegorz Bulaj; Raymond S Norton
Journal:  Future Med Chem       Date:  2014-10       Impact factor: 3.808

4.  Aberrant epilepsy-associated mutant Nav1.6 sodium channel activity can be targeted with cannabidiol.

Authors:  Reesha R Patel; Cindy Barbosa; Tatiana Brustovetsky; Nickolay Brustovetsky; Theodore R Cummins
Journal:  Brain       Date:  2016-06-05       Impact factor: 13.501

5.  The Changes of Intrinsic Excitability of Pyramidal Neurons in Anterior Cingulate Cortex in Neuropathic Pain.

Authors:  Zhilai Yang; Qilian Tan; Dan Cheng; Lei Zhang; Jiqian Zhang; Er-Wei Gu; Weiping Fang; Xianfu Lu; Xuesheng Liu
Journal:  Front Cell Neurosci       Date:  2018-11-21       Impact factor: 5.505

6.  Atrioventricular Nodal Reentrant Tachycardia Triggered by Marijuana Use: A Case Report and Review of the Literature.

Authors:  Pramod Theetha Kariyanna; Apoorva Jayarangaiah; Oleg Yurevich; Jonathan Francois; Denis Yusupov; Angelina Zhyvotovska; Louis Salciccioli; Sudhanva Hegde; Samy I McFarlane
Journal:  Am J Med Case Rep       Date:  2019-07-16

7.  Marijuana and Cardiac Arrhythmias: A Scoping Study.

Authors:  Pramod Theetha Kariyanna; Perry Wengrofsky; Apoorva Jayarangaiah; Syed Haseeb; Louis Salciccioli; Sudhanva Hegde; Jonathan D Marmur; Yasmin Soliman; Sama Al-Bayati; Samy I McFarlane
Journal:  Int J Clin Res Trials       Date:  2019-02-22
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.